Skip to main content

Ernexa Therapeutics Inc.

ERNAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000748592

No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $202.3K in total; no superinvestor holds it.

Other share classesERNA

Members of Congress who traded ERNAW

No member of Congress has reported a trade in Ernexa Therapeutics Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.